The effect of Cardamom supplementation on serum lipids, glucose and blood pressure in prediabetic women

The effect of Cardamom supplementation on serum lipids, glycemic indices and blood pressure in overweight and obese prediabetic women

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2014060817254N2

Enrollment

Registered

2014-09-02

Start date

2013-03-20

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pre diabetes. Impaired glucose tolerance Prediabetes

Interventions

Intervention 1: group receiving green cardamom :capsules containing 1g cardamom, three a day for 2 month. Intervention 2: placebo group receiving rusk powder: capsules containing 1g of rusk powder, th

Placebo

group receiving green cardamom :capsules containing 1g cardamom, three a day for 2 month

placebo group receiving rusk powder: capsules containing 1g of rusk powder, three a day for 2 month

Eligibility

Sex/Gender

Female

Age

30 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Prediabetic women with one of the following criteria: FBS; 100-125 mg/dl, HbA1C: 5.7-6.4, 2hpp blood glucose: 140-199 mg/dl; Age: 30-70 years; BMI: 25-39.9 kg/m2; Having at least one of the following criteria: TG>150 mg/dl, Chol>200 mg/dl, LDL>100 mg/dl, HDL130/80 mmHg; LDL>160 mg/dl; TG>300 mg/dl. Exclusion criteria: Multi vitamin and anti oxidant supplements consumption during the intervention; Changes in diet or physical activity; Not intaking of more than 10% of supplements; Morbidity to diabetes during the intervention.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Serum Triglycerid. Timepoint: before and after the intervention. Method of measurement: Enzymatic Measurement of fasting Serum Triglycerid by using kits.;Serum LDL. Timepoint: before and after the intervention. Method of measurement: Enzymatic Measurement of fasting serum LDL by using kits.;Fasting blood sugar. Timepoint: before and after the intervention. Method of measurement: Enzymatic Measurement of fasting blood sugar by using kits.;Serum cholesterol. Timepoint: before and after the intervention. Method of measurement: Enzymatic Measurement of fasting serum cholesterol by using kits.;Serum HDL. Timepoint: before and after the intervention. Method of measurement: Enzymatic Measurement of fasting serum HDL by using kits.;Serum insulin concentration. Timepoint: before and after the intervention. Method of measurement: Enzymatic Measurement of serum insulin concentration by using kits.;Insulin sensitivity. Timepoint: before and after the intervention. Method of measurement: QUIKI formula.;Insulin Resistance. Timepoint: before and after the intervention. Method of measurement: HOMA-IR formula.;Systolic blood pressure. Timepoint: before and after the intervention. Method of measurement: Measured with a manometer.;Diastolic blood pressure. Timepoint: before and after the intervention. Method of measurement: Measured with a manometer.	—

Measure

Time frame

Serum Triglycerid. Timepoint: before and after the intervention. Method of measurement: Enzymatic Measurement of fasting Serum Triglycerid by using kits.;Serum LDL. Timepoint: before and after the intervention. Method of measurement: Enzymatic Measurement of fasting serum LDL by using kits.;Fasting blood sugar. Timepoint: before and after the intervention. Method of measurement: Enzymatic Measurement of fasting blood sugar by using kits.;Serum cholesterol. Timepoint: before and after the intervention. Method of measurement: Enzymatic Measurement of fasting serum cholesterol by using kits.;Serum HDL. Timepoint: before and after the intervention. Method of measurement: Enzymatic Measurement of fasting serum HDL by using kits.;Serum insulin concentration. Timepoint: before and after the intervention. Method of measurement: Enzymatic Measurement of serum insulin concentration by using kits.;Insulin sensitivity. Timepoint: before and after the intervention. Method of measurement: QUIKI formula.;Insulin Resistance. Timepoint: before and after the intervention. Method of measurement: HOMA-IR formula.;Systolic blood pressure. Timepoint: before and after the intervention. Method of measurement: Measured with a manometer.;Diastolic blood pressure. Timepoint: before and after the intervention. Method of measurement: Measured with a manometer.

—

Secondary

Measure	Time frame
Weight. Timepoint: before and after the intervention. Method of measurement: Measured with a digital scale.;BMI. Timepoint: before and after the intervention. Method of measurement: Measured with formula.;Waist circumference. Timepoint: before and after the intervention. Method of measurement: measurement with a meter.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Yaghooblou

Tehran university of Medical Sciences

yaghooblou.fatemeh@yahoo.com+98 26 3451 4381

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Mar 8, 2026